miR-423 Promotes Breast Cancer Invasion by Activating NF-κB Signaling.

作者: Ting Dai , Xiaohui Zhao , Yun Li , Lihong Yu , Yanan Li

DOI: 10.2147/OTT.S236514

关键词:

摘要: Objective Breast cancer has become the most common malignancy among women worldwide; therefore, novel diagnostic and prognostic markers therapeutic targets are urgently required. NF-κB signaling plays a pivotal role in enhancing breast malignant phenotypes, especially invasion metastasis, which is main cause of death patients. TNIP2, an important inhibitor pathway, known to involve negative feedback loop cascade regulate tumor aggressiveness various types. However, mRNA level TNIP2 barely altered cancer; thus, mechanism that regulates still needs be elucidated. Methods We analyzed expression prognosis miR-423 TCGA BRCA miRNA cohort clinical specimens. detected invasive capacity through Matrigel-coated Transwell penetration assay, three-dimensional (3D) spheroid assay wound healing assay. Then, we applied luciferase assays, real-time PCR assays Western blotting further study mechanism. Results In this study, analysis specimens demonstrated was upregulated human cancers positively correlated with stage, poor overall survival metastasis classification. Moreover, invasiveness cells enhanced by ectopic inhibited downregulation. Mechanistically, upregulation led activation pathway elevated snail twist, while repression pathway. Furthermore, results indicated target gene miR-423, suppression resulted increased miR-423-silenced cells. Conclusion Our suggest crucial factor enhances cell shed light on as promising marker for metastatic cancer.

参考文章(49)
Aurora Esquela-Kerscher, Frank J. Slack, Oncomirs — microRNAs with a role in cancer Nature Reviews Cancer. ,vol. 6, pp. 259- 269 ,(2006) , 10.1038/NRC1840
Chunyan Liu, Lina Wang, Weiwen Chen, Shihu Zhao, Chunli Yin, Yani Lin, Anli Jiang, Pengju Zhang, USP35 activated by miR let-7a inhibits cell proliferation and NF-κB activation through stabilization of ABIN-2 Oncotarget. ,vol. 6, pp. 27891- 27906 ,(2015) , 10.18632/ONCOTARGET.4451
A. Cimmino, G. A. Calin, M. Fabbri, M. V. Iorio, M. Ferracin, M. Shimizu, S. E. Wojcik, R. I. Aqeilan, S. Zupo, M. Dono, L. Rassenti, H. Alder, S. Volinia, C.-g. Liu, T. J. Kipps, M. Negrini, C. M. Croce, miR-15 and miR-16 induce apoptosis by targeting BCL2. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 102, pp. 13944- 13949 ,(2005) , 10.1073/PNAS.0506654102
Jun H. Lee, Anjan Nan, Combination Drug Delivery Approaches in Metastatic Breast Cancer Journal of drug delivery. ,vol. 2012, pp. 915375- 915375 ,(2012) , 10.1155/2012/915375
Michael Karin, Florian R. Greten, NF-kappaB: linking inflammation and immunity to cancer development and progression. Nature Reviews Immunology. ,vol. 5, pp. 749- 759 ,(2005) , 10.1038/NRI1703
Girieca Lorusso, Curzio Rüegg, New insights into the mechanisms of organ-specific breast cancer metastasis. Seminars in Cancer Biology. ,vol. 22, pp. 226- 233 ,(2012) , 10.1016/J.SEMCANCER.2012.03.007
L Huang, L Verstrepen, K Heyninck, A Wullaert, H Revets, P De Baetselier, R Beyaert, ABINs inhibit EGF receptor-mediated NF-kappa B activation and growth of EGF receptor-overexpressing tumour cells Oncogene. ,vol. 27, pp. 6131- 6140 ,(2008) , 10.1038/ONC.2008.208